高级检索
当前位置: 首页 > 详情页

The efficacy and safety of RC88 in patients with ovarian cancer, non-squamous-non-small-cell lung-carcinoma and cervical cancer: Results from a first-in-human phase 1/2 study

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

机构: [1]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China [2]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [3]Yunnan Cancer Hospital, Kunming, China [4]Chongqing University Cancer Hospital, Chongqing, China [5]Henan Cancer Hospital, Zhengzhou, China [6]Shandong Cancer Hospital, Jinan, Shandong, China [7]Shandong Cancer Hospital, Jinan, China [8]Tianjin Medical University Cancer Institute and Hospital, Tianjin, China [9]Hubei Cancer Hospital, Wuhan, China [10]Hunan Cancer Hospital, Changsha, China [11]Qilu Hospital of Shandong University, Jinan, China [12]First Hospital of Jilin University, Changchun, China [13]Nanjing Drum Tower Hospital, Nanjing, China [14]Sichuan Cancer Hospital, Chengdu, China [15]RemeGen Co., Ltd., Yantai, China [16]School of Life Science and Technology, Tonji Univesity, Shanghai, China
出处:
ISSN:
基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号